Chairs: James Wilmott & Golo Ahlenstiel
INVITED SPEAKERS: CAMERON TURTLE & NIKOLA BOWDEN
Factors governing outcomes of CD19 CAR-T cell immunotherapy for B cell malignancies (#4)
11:00 AM
Drug repurposing to overcoming immunotherapy resistance (#5)
11:20 AM
The Tolls to be paid: the detrimental impact of TLR4 rs11536889 on Helicobacter pylori-related stomach cancer (#6)
11:40 AM
Immunospatial tumour immune microenvironment (isTIME) organisation is associated with recurrence in primary melanoma (#7)
11:50 AM
Deciphering the Crosstalk within the Tumor Microenvironment of NSCLC by a virtual microdissection approach (#8)
12:00 PM
Evaluating the safety and effect of chemotherapy and localised immunotherapy for the treatment of inoperable pancreatic cancer using an implantable device (#9)
12:10 PM
Immune predictors of response to immunotherapy in metastatic cSCC (#10)
12:20 PM
HIGH-RISK HUMAN PAPILLOMAVIRUS DETECTION IN LYMPH NODE METASTASIS OF OESOPHAGEAL ADENOCARCINOMA; A WORLD-FIRST PILOT STUDY (#11)
12:30 PM